MedPath
NMPA Approval

Cabotegravir Injection

国药准字HJ20230093

July 11, 2023

Drug Information

卡替拉韦注射液

万凯锐

注射剂

3ml∶0.6g

化学药品

July 11, 2023

July 10, 2028

Company Information

Applicant Company

ViiV Healthcare BV

Van Asch van Wijckstraat 55H, 3811 LP Amersfoort, Netherlands

Manufacturing Company

glaxo operations uk ltd (trading as glaxo wellcome operations)

Harmire Road, Barnard Castle, County Durham DL12 8DT, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

卡替拉韦注射液 - NMPA 批准文号 | MedPath